Success Metrics

Active Trials
4(50%)

Phase Distribution

Ph phase_2
2
25%
Ph phase_1
1
13%
Ph not_applicable
1
13%
Ph phase_3
3
38%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Other(4)

Detailed Status

unknown4
Recruiting3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 33 (42.9%)
N/A1 (14.3%)

Trials by Status

recruiting338%
active_not_recruiting113%
unknown450%

Recent Activity

4 active trials
Showing 5 of 8
recruitingnot_applicable

Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer

NCT07669298
active_not_recruitingphase_1

Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer

NCT05667298
recruitingphase_2

Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC

NCT05272696
recruitingphase_3

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

NCT06427447
unknown

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

NCT04737551
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07669298Not Applicable

Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer

Recruiting
NCT05667298Phase 1

Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer

Active Not Recruiting
NCT05272696Phase 2

Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC

Recruiting
NCT06427447Phase 3

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

Recruiting
NCT04737551

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Unknown
NCT02371304Phase 3

Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers

Unknown
NCT03973008Phase 3

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

Unknown
NCT01463501Phase 2

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

Unknown

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8